Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Giudice, Michele Miraglia del
NCT06191315: Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)	Recruiting	3	90	Europe, Canada, US, RoW	Dupilumab, SAR231893, Dupixent, Placebo	Sanofi, Regeneron Pharmaceuticals	Wheezing, Asthma	12/28	12/28
NCT04408443: Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients	Terminated	N/A	200	Europe	Lactobacillus reuteri DSM 17938 + Vitamine D3, Placebo	Noos S.r.l.	Recurrent Respiratory Tract Infections	09/21	09/21
NCT05684848: Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing	Recruiting	N/A	252	Europe	Resveratrol + CMG, Isotonic solution	Noos S.r.l.	Wheezing, Recurrent Respiratory Tract Infections	12/23	05/24